117 participants
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-12-21
- Start Date:
- 2018-04-25
- Completion:
- 2022-12-28
Conditions
- Non-Small Cell Lung Cancer
- Renal Cell Cancer
- Colorectal Cancer
- Triple Negative Breast Cancer
- Cervical Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Endometrial Cancer
- Sarcoma
- Squamous Cell Carcinoma of the Head and Neck
- Bladder Cancer
- Metastatic Castration Resistant Prostate Cancer
- Non-hodgkin Lymphoma
Interventions
- DRUG
No Results Yet